Global University Venturing

The edge computing technology developer has reportedly been purchased by Apple, three years after being spun out of AI2 to advance work by University of Washington's Ali Farhadi.

UW spinout Nicoya has its sight set on product development and business expansion after a series A round featuring UW Student Venture Fund and Wilfrid Laurier University’s Startup Fund.

Ian Postlethwaite will exit as CEO of NetScientific this July as the embattled commercialisation firm continues to patch up its balance sheet.

University of Pittsburgh Medical Center’s venture arm has allocated $1bn to drugs, diagnostics and devices development, including a $200m partnership with the university.

Treadwell has launched with seed funding from Tio Bioventures to commercialise small molecule cancer drugs based on University Health Network research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Subsidiaries of Astellas and Novartis co-led a series B round that took Harvard's cancer treatment developer's overall funding to $60m.

Pavilion Capital and Hansjörg Wyss featured in a series B round for Harvard-founded ReadCoor, whose existing shareholders also include Lilly Asia Ventures.

Fusion Pharmaceuticals has now raised $171m altogether to deliver cancer radiopharmaceuticals based on McMaster University research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Jasper Therapeutics, based in part on Stanford research, has raised a $15m series A extension on the back of early clinical results from its blood transplant conditioning program.